Modeling supply chain best practices for better pandemic readiness in pharmacy
- Funded by Netherlands Organisation for Health Research and Development (ZonMW)
- Total publications:0 publications
Grant number: 1.07101E+13
Grant search
Key facts
Disease
Disease XStart & end year
20242026Known Financial Commitments (USD)
$0Funder
Netherlands Organisation for Health Research and Development (ZonMW)Principal Investigator
prof dr ir SLJM de LeeuwResearch Location
NetherlandsLead Research Institution
Wageningen University & ResearchResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Therapeutics logistics and supply chains and distribution strategies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The COVID-19 Pandemie led to life-threatening drug shortages and thus brought renewed attention to the importance of medicine availability. This pandemic exposed vulnerabilities in the Dutch pharmaceutical supply chain (FSC) that are strongly influenced by regulations, price strategies and the organization of the supply chain. To be better prepared for a pandemic in the future, the European Partnership for Pandemic Preparedness recommends tackling the core problems in the FSC.